Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
INGRADIENT, Inc. logo — artificial intelligence, medical supply, software developmen...

INGRADIENT, Inc.

artificial intelligence, medical supply, software development

Founded 2020 Korea South Korea South 5 employees Seed Total: $1.40B Information Technology

General Information

Company Name INGRADIENT, Inc.
Founded Year 2020
Location Korea South Korea South
Employees 5
Industries Information Technology
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with INGRADIENT, Inc.. To contact INGRADIENT, Inc., visit ingradient.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does INGRADIENT, Inc. compare?

A PDF of INGRADIENT, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting INGRADIENT, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About INGRADIENT, Inc.

INGRADIENT, Inc. is a medical artificial intelligence (AI) data labeling company that has developed a cutting-edge software called "MediLabel" . This innovative technology is specifically designed for processing data for healthcare professionals and researchers, catering to the rapidly evolving medical industry. Established in 2020 and headquartered in South Korea , the company recently secured a KRW1.40B investment in a Seed Round on 06 July 2021 . The notable investors in this round include Nextrans, Yozma Group Korea, Genaxis, Vision Creator . The focus of INGRADIENT, Inc. on artificial intelligence, medical supply, and software development aligns with the growing demand for advanced technological solutions within the healthcare sector. The successful funding round indicates investor confidence in the potential of MediLabel and the company's vision. With the backing of strategic investors, the company is well-positioned to expand its reach and further develop its AI-driven software to meet the evolving needs of healthcare professionals and medical researchers. In the dynamic and competitive landscape of Information Technology , INGRADIENT, Inc. signifies a promising player, poised for growth and innovation. The company's focus on leveraging AI for medical data processing presents compelling opportunities in an industry where technological advancements are increasingly crucial. As INGRADIENT, Inc. continues to progress, its innovative approach and strategic alliances with prominent investors position it as a noteworthy contender in the evolving intersection of technology and healthcare.

Business keywords: Medical Technology, Data Labeling, Healthcare Data Processing, Research Data Management, Software Development, Medical Research, Healthcare Analytics, Data Processing Solutions, Innovation in Healthcare, Healthcare IT, Medical Software, AI in Medicine, HealthTech, Medical Data Analysis

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round KRW1.40B 4
Nextrans Yozma Group Korea Genaxis
Nextrans, Yozma Group Korea +2
06 Jul 2021

INGRADIENT, Inc. Alternatives & Competitors

View All Alternatives
INGRADIENT, Inc. vs
Kiro
Kiro France

Artificial intelligence serving clinical biology

Series A
50 employees
AI, Information Technology
INGRADIENT, Inc. vs
medicalvalues GmbH
medicalvalues GmbH Germany

Artificial Intelligence supporting Medical Diagnostics

31 employees
Information Technology, SaaS
INGRADIENT, Inc. vs
FlowView Diagnostics
FlowView Diagnostics The Netherlands

AI-powered intelligent decision support for precise and automated flow cytometry data analysis.

Series A
3 employees
Health Care, Information Technology
View all alternatives

FAQ About INGRADIENT, Inc.

artificial intelligence, medical supply, software development
INGRADIENT, Inc. was founded in 2020.
INGRADIENT, Inc. is headquartered in Korea South.
INGRADIENT, Inc. operates in Information Technology. Its work centres on Medical Technology, Data Labeling, Healthcare Data Processing and Research Data Management.
INGRADIENT, Inc. has approximately 5 employees.
INGRADIENT, Inc. has completed 1 funding round, raising a total of $1.40B. The latest funding stage is Seed.
Top alternatives and competitors to INGRADIENT, Inc. include Kiro, medicalvalues GmbH, FlowView Diagnostics, Xenolytix, MedAware Systems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
INGRADIENT, Inc. and Kiro are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for INGRADIENT, Inc., https://bouncewatch.com/company/ingradient-inc, updated 9 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes